NGN Capital
NGN Capital is a venture capital firm specializing in investments in the US and European healthcare sector. The fund focuses specifically on investments in the healthcare, pharmaceutical, and biotech sectors including drug products, medical devices, diagnostics, and healthcare services.
Recent Milestones
Investments
Videos
Sources
-
Endosense Raises $40.3M in Series C Funding (finsmes.com)
[edit]
-
Small Bone Innovations Raises $15M in Series F Financing (finsmes.com)
[edit]
-
Artisan Pharma adds $3M to coffers in new round (masshightech.com)
[edit]
-
Exosome Diagnostics Completes $20 Million Series A Financing (exosomedx.com)
[edit]
-
Valtech Cardio, Ltd.: Series B $17.8M (onbiovc.com)
[edit]
-
Artisan Pharma Raises $22 Million Series B Financing (artisanpharma.net)
[edit]
-
BeneChill, Inc.: Series C $13.5M (onbiovc.com)
[edit]
-
Raises Series D round of $108mm - one of the largest private equity capital financings for an orthopedic company (totalsmallbone.com)
[edit]
-
Aerovance inhales $38M for asthma drugs (venturebeat.com)
[edit]
-
CeraPedics, Inc. Raises $15 Million (devicespace.com)
[edit]
-
SEC D (sec.gov)
[edit]
-
Raises Series C round of $36mm (totalsmallbone.com)
[edit]
-
Aerovance, asthma treatment company, finishes raising $60M (deals.venturebeat.com)
[edit]
-
Artisan Pharma, Inc. Raises $39 Million in a Series A Financing Led by NGN Capital LLC (artisanpharma.net)
[edit]
-
EKOS® CORPORATION ESTABLISHES SALES AND MARKETING TEAM FOLLOWING COMPLETION OF $26 MILLION SERIES C FINANCING (ekoscorp.com)
[edit]
-
EKOS Corporation Raises $18 Million in Series B Financing (ekoscorp.com)
[edit]